Wilson Sonsini Goodrich & Rosati advised Yext on the transaction. Yext, Inc. (NYSE: YEXT), a leading digital presence platform for multi-location brands, announced its acquisition of...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Protex AI on the transaction. Protex AI, the global leader in AI-driven workplace safety technology, announced it has secured an...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Origen on the transaction. The company will use the capital to scale its limestone-based direct air capture (DAC) technology to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented 9fin; Osborne Clarke advised Highland Europe. 9fin, the AI-powered analytics platform for debt capital markets, announced it has raised $50...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised 11x on the transaction. 11x, the leader in AI-powered digital workers for revenue teams, announced the closing of a $50...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BlackSky on the transaction and Faegre Drinker Biddle & Reat advised the underwriters. BlackSky Technology Inc. (NYSE: BKSY), a real-time,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Insider on the transaction. Insider, a leading AI-native omnichannel experience and customer engagement platform, announced raising $500 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ahren, OMX Ventures, +ND Capital, and Fine Structures Ventures on the transaction. Constructive Bio, a pioneering synthetic genomics company, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aembit on the transaction. Aembit, a leading non-human identity and access management (IAM) company, has secured $25 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Amber on the transaction. Amber Therapeutics, a UK-based medical technology company, announced it closed a Series A financing, raising $100...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati, P.C. is advising Yext on the transaction, and Latham & Watkins is advising Hearsay Systems. Yext, Inc. (NYSE: YEXT), the leading...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Hyperexponential in the transaction. Osborne Clarke advised Highland Europe. Hyperexponential announced the closing of its $73 million Series B funding round led...
You must be a Standard 1 Year member to access this content.
